1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porters Five Forces 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threats of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Companies Promoting Personalized Medicine and Targeted Therapy as a New Treatment Option 6.1.2 Increasing Cases of Adverse Drug Reactions 6.1.3 Co-Development of Drug and Diagnostic Technology 6.2 Market Restraints 6.2.1 High Cost Of Drug Development and Associated Clinical Trials 6.2.2 Reimbursement Issues among Many Countries 7. Market Segmentation 7.1 By Technology 7.1.1 Immunohistochemistry (Ihc) 7.1.2 Polymerase Chain Reaction (Pcr) 7.1.3 In Situ Hybridization (Ish) 7.1.4 Real-Time Pcr (Rt-Pcr) 7.1.5 Gene Sequencing 7.1.6 Others 7.2 By Indication 7.2.1 Lung Cancer 7.2.2 Breast Cancer 7.2.3 Coloractal Cancer 7.2.4 Leukemia 7.2.5 Melanoma 7.2.6 Others 7.3 Segmentation by Geography 7.3.1 North America 7.3.1.1 United States 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 United Kingdom 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest of Europe 7.3.3 Asia-Pacific 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 Australia & New Zealand 7.3.3.5 South Korea 7.3.3.6 Rest of Asia-Pacific 7.3.4 Middle East and Africa 7.3.4.1 GCC 7.3.4.2 South Africa 7.3.4.3 Rest of Middle East and Africa 7.3.5 South America 7.3.5.1 Brazil 7.3.5.2 Argentina 7.3.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers and Acquisition Analysis 8.2 Agreements, Collaborations & Partnerships 8.3 New Products Launches 9. Key Players 9.1 Abbott Laboratories 9.2 Dako (Agilent Technologies) 9.3 Roche Holdings 9.4 Qiagen Nv 9.5 Seimens Helthineers 9.6 Takeda Pharmaceuticals 9.7 Myriad Genetics 9.8 Thermo Fisher Scientific 9.9 Tocagen 9.10 Illumina Inc 9.11 Others 10. Future of The Market

Abbott Laboratories,Dako (Agilent Technologies),Roche Holdings,Qiagen nv,Seimens Helthineers,Takeda Pharmaceuticals,Myriad Genetics,Thermo Fisher Scientific,Tocagen,Illumina inc